University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
672 Ergebnisse für "therapeutics com com com" unter University of Zurich
UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke
... Susanne Nieke, Dipl. rer. com. Wissenschaftliche Mitarbeiterin ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke Home Main navigation Search ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ...
added the tests for the functions GraphToModela nd JsonObjectToTime...
... ) · Com ... ) · Com ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1391 Ergebnisse für "therapeutics com com com" unter ETH Entrepreneurship
Consequences of pseudo-participatory approaches towards post-disast...
... com ... com ...
Thin Polymeric Materials and Processing Routes for Novel Cardiovasc...
... Com ... Com ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
881 Ergebnisse für "therapeutics com com com" unter Somagenetix
Open Intrauterine Fetal Myelomeningocele Repair: Changes in the Sur...
... Com ... Com ...
Accuracy of CBCT-based root canal length predetermination using new...
... com ... com ...
Molecular Partners AG
http://www.molecularpartners.com
8952 Schlieren, Wagistrasse 14
+41 44 755 77 00
Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.
Molecular Partners AG
Wagistrasse 14
8952 Schlieren
82 Ergebnisse für "therapeutics com com com" unter Molecular Partners AG
Actavis confirms timeline for the start of phase III development of...
... ophthalmology Molecular Partners has a strong focus on creating differentiated therapeutics for retinal diseases ... ™, a product that inhibits both VEGF and PDGF, through preclinical and clinical development to com ... ophthalmology Molecular Partners has a strong focus on creating differentiated therapeutics for retinal diseases ... ™, a product that inhibits both VEGF and PDGF, through preclinical and clinical development to com ...
Shareholders of Molecular Partners AG approved all Board proposals ...
... also re-elected. The shareholders of Molecular Partners AG also approved the proposed respective com ... therapeutics. The DARPin technology has the potential to enable a “multi-benefit” approach to treatment which ... Partners AG also approved the proposed respective com-pensation amounts for the Board of Directors and the ... conventional monoclonal antibodies or other current-ly available protein therapeutics. The DARPin technology ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
28 Ergebnisse für "therapeutics com com com" unter Kuros Biosciences AG
... successfully. The phase 2b study in patients with allergic asthma is com pletely recruited and the main data of ... field of development of asthma therapeutics and, after reassessment of the facts, to replace resolution ... successfully. The phase 2b study in patients with allergic asthma is com pletely recruited and the main data of ... field of development of asthma therapeutics and, after reassessment of the facts, to replace resolution ...
... implants are to be inserted. The prospective clinical trial will com- pare MagnetOs Granules to autologous ... (mother company and 100% shareholder of following subsid- iaries) - Proteome Therapeutics Limited ... implants are to be inserted. The prospective clinical trial will com- pare MagnetOs Granules to autologous ... (mother company and 100% shareholder of following subsid- iaries) - Proteome Therapeutics Limited ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
156 Ergebnisse für "therapeutics com com com" unter Roche Glycart AG
Roche launches SARS-CoV-2 molecular test to aid in the public healt...
... therapeutics, vaccines and public health interventions Periodic assessments against emerging variants have ... diagnostics, vaccines and therapeutics, providing crucial insight for healthcare systems in making appropriate ... variants and monitor their potential impact on therapeutics, vaccines and public health interventions ... assess any potential impact on diagnostics, vaccines and therapeutics, providing crucial insight for ...
Roche launches SARS-CoV-2 variant test to help monitor emerging cor...
... potential impact on therapeutics, vaccines and public health interventions Periodic assessments against ... potential impact on diagnostics, vaccines and therapeutics, providing crucial insight for healthcare systems ... variants and monitor their potential impact on therapeutics, vaccines and public health interventions ... prevalence and to assess any potential impact on diagnostics, vaccines and therapeutics, providing crucial ...
InCephalo AG
8952 Schlieren, Wagistrasse 21
InCephalo develops exclusively local treatments for neurological diseases, with a focus on cancers in the brain (primary brain cancers as well as secondary brain cancers). The proprietary Compartment Lock technology, also called C-Lock, retains biologics, that are applied locally behind the blood brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrades them rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects). Especially the peripheral side effects still limit various promising candidates for the treatment of brain cancer or other neurological diseases.
InCephalo AG
Wagistrasse 21
8952 Schlieren
17 Ergebnisse für "therapeutics com com com" unter InCephalo AG
InCephalo Therapeutics
... Developing Compartment Locked (C-Locked) therapeutics InCephalo develops exclusively local ... InCephalo Therapeutics ... InCephalo Therapeutics Skip to content Main Menu Home About Our Approach Pipeline Team Contact News ... InCephalo Therapeutics ...
InCephalo Therapeutics
... InCephalo Therapeutics InCephalo Therapeutics NEW Website ready ... InCephalo Therapeutics ... InCephalo Therapeutics InCephalo Therapeutics NEW Website ready ... InCephalo Therapeutics ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
69 Ergebnisse für "therapeutics com com com" unter Blutspende SRK Zürich
... Therapeutics Find the latest version: https://jci.me/158190/pdf The Journal of Clinical Investigation C L I N I ... as com- posite total antibody reactivities, on time to viral clearance (Figure 4A, Supplemental ... Therapeutics Find the latest version: https://jci.me/158190/pdf The Journal of Clinical Investigation C L I N I ... as com- posite total antibody reactivities, on time to viral clearance (Figure 4A, Supplemental ...
... did not result in a delay regarding surgical treatment for OA, com- pared with placebo. The findings ... . Wehling P, Moser C, Maixner W. How does surgery com- pare with advanced intra-articular therapies in knee ... did not result in a delay regarding surgical treatment for OA, com- pared with placebo. The findings ... . Wehling P, Moser C, Maixner W. How does surgery com- pare with advanced intra-articular therapies in knee ...
Virometix AG
8952 Schlieren, Wagistrasse 14
+41 (0)43 433 86 60
info@virometix.com
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
Virometix AG
Wagistrasse 14
8952 Schlieren
2 Ergebnisse für "therapeutics com com com" unter Virometix AG
Newsroom - Virometix AG
... . pneumoniae vaccine program PoC achieved Peptide Therapeutics Forum 2022 Virometix strengthens its team ... August – 02 September 2022; https://www.eps2022. com/ ). With presentations on our T-cell epitope SARS-CoV ... of scientific interest and gained valuable new chemistry knowledge. Peptide Therapeutics Forum 2022 ...
About us - Virometix AG
... , metabolism, anti-infectives, and vaccines). He is currently on the board of Tolremo Therapeutics. Christina ... -executive member of the boards of Onconetix Inc. (NASDAQ: ONCO) and Entero Therapeutics Inc. (NASDAQ: ENTO ... Therapeutics. Board of Directors Christina Ackermann Chairman Christina Ackermann brings over 27 years of ... Onconetix Inc. (NASDAQ: ONCO) and Entero Therapeutics Inc. (NASDAQ: ENTO). He received his B.S. in Biology ...
Standortförderung Kanton Zürich
https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html
8090 Zürich, Walchestrasse 19
+41 43 259 49 92
standort@vd.zh.ch
The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.
Standortförderung Kanton Zürich
Walchestrasse 19
8090 Zürich
16 Ergebnisse für "therapeutics com com com" unter Standortförderung Kanton Zürich
Executive Summary Cluster Study Life Sciences Zurich 2021/22
... least because numerous companies are involved in research and development of Covid-19 therapeutics and ... diagnostics. Examples include Molecular Partners, Memo Therapeutics, InSphero, Biognosys and Neurimmune. With ... least because numerous companies are involved in research and development of Covid-19 therapeutics and ... diagnostics. Examples include Molecular Partners, Memo Therapeutics, InSphero, Biognosys and Neurimmune. With ...
Urban Mining (English): literature antimony
... the Total Environment 409, 6126-5128. http://www.sciencedirect. com/science/article/pii ... -100. http://www.sciencedirect. com/science/article/pii/S0269749102004116, 13.01.2014. 22 Grund, S.C ... the Total Environment 409, 6126-5128. http://www.sciencedirect. com/science/article/pii ... -100. http://www.sciencedirect. com/science/article/pii/S0269749102004116, 13.01.2014. 22 Grund, S.C ...